CIVM 2023 Day 2 : Breakout Sessions — Drafting a Qualification Utilizing Sessions 1, 2, and 3 Published 2024-02-22 Download video MP4 360p Recommendations 33:26 Clinical Outcome Assessment — Initial Public Discussion 15:02 CIVM Workshop Day One: Perspective on Translating New Drug Development Tools into Regulatory Use 22:01 SBS Day 2 - Disease Prevention in T1D and Neonates Panel 57:02 4. Descriptive and Analytical Studies | CPP NCD Epidemiology 30:56 Amazon Kinesis Introduction and Overview (with SNS, SQS, Eventbridge Comparisons!) 57:01 Hidden in Plain Sight: Autosomal Dominant Tubulointerstitial Kidney Disease 50:12 Inflammation | Vascular Events | Immunology | Dr Najeeb 41:06 C-Path Roundtable: C-Path, Help4HD Unite to Discuss Advancements in Huntington's Disease Treatments 56:42 Improving Data Collection for Rare Epilepsies: Case example from the TSC Natural History Database 08:56 Randomized Controlled Trials (RCTs) 1:03:26 Advanced Pharmaceutical Manufacturing 2:14:29 Rare Neurodegenerative Disease Efforts Under the ACT for ALS 1:00:19 The Use and Development of DHTs with Patient Advocacy Groups 1:09:28 SBS Day 2 - Panel IV-b Considerations for Clinical Trial Design Optimization in Neonates and T1D 14:59 Medical Terminology - The Basics - Lesson 1 46:45 Configuring Elasticsearch Index for Time Series Data 1:10:15 SBS Day 2 - Session III-b: Disease Prevention in Lysosomal Diseases 23:44 Session 1: Dr Ryan Gately & Dr Laura De Souza BK Polyomavirus Update 55:53 SBS Day 2 - Session IV: Clinical Trial Design Considerations 17:31 SBS Day 2 - INC current perspective: Conducting gene therapy clinical trials